INM Company Profile and Key Details

Q: Who are the executives of INM?

Dr. Sazzad Hossain M.Sc., Ph.D.Co-FounderMr. Michael Woudenberg P.Eng.Chief Operating OfficerDr. Shane A. Johnson Ph.D.Senior Vice President & GM of BayMedicaMs. Sarah Li C.P.A., CGAVice President of Accounting & ControllerMs. Brenda Edwards C.M.A., C.P.A.Chief Accounting OfficerDr. Ado MuhammadSenior Consultant of Medical AffairsMr. Jonathan R. TeggeInterim Chief Financial OfficerMs. Sarah LiVice President of Accounting, Controller & Principal Accounting OfficerDr. Eric Chih-Hsien HsuSenior Vice President of Preclinical R&DMs. Sarah Li CPA, CGAVice President of Accounting & ControllerColin ClancySenior Director of Investor RelationsMs. Alexandra Diane-Janet Mancini M.Sc.Senior Vice President of Clinical & Regulatory AffairsMr. Jerry P. GriffinVice President of Sales & MarketingMr. Eric A. Adams B.S. Chem., M.I.B.Pres, Chief Executive Officer & Director

NASDAQ : INM

InMed Pharmaceuticals

$1.60

0.9193+135.05%

At Close 4:00 PM

$1.68

+0.08+5.16%

After-Market 08:30 PM

63.64

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

InMed Pharmaceuticals Inc. (INM) stock surged +135.05%, trading at $1.60 on NASDAQ, up from the previous close of $0.68. The stock opened at $1.79, fluctuating between $1.31 and $1.79 in the recent session.

Stock Snapshot

0.6807

Prev. Close

2.9M

Market Cap

1.31

Day Low

-1.09

P/E Ratio

-1.47

EPS (TTM)

-0.82

Cash Flow per Share

1.79

Open

1.81M

Number of Shares

1.79

Day High

98.44%

Free Float in %

1.6

Book Value

91.54M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 19, 2026	1.79	1.80	1.31	1.60	92.46M
May 18, 2026	0.69	0.71	0.68	0.68	10.39K
May 15, 2026	0.66	0.68	0.64	0.64	10.33K
May 14, 2026	0.68	0.69	0.63	0.65	15.03K
May 13, 2026	0.64	0.66	0.63	0.63	9.13K
May 12, 2026	0.62	0.67	0.62	0.66	19.18K
May 11, 2026	0.66	0.68	0.62	0.62	25.16K
May 08, 2026	0.72	0.73	0.65	0.65	12.13K
May 07, 2026	0.73	0.79	0.69	0.70	35.49K
May 06, 2026	0.74	0.76	0.73	0.73	16.25K
May 05, 2026	0.73	0.77	0.73	0.74	12.7K
May 04, 2026	0.71	0.78	0.71	0.75	5.65K
Apr 30, 2026	0.70	0.76	0.70	0.72	31.93K
Apr 29, 2026	0.75	0.75	0.70	0.70	14.1K
Apr 28, 2026	0.73	0.76	0.70	0.70	16.25K
Apr 27, 2026	0.78	0.80	0.73	0.73	24.9K
Apr 23, 2026	0.81	0.81	0.74	0.76	39.72K
Apr 22, 2026	0.74	0.82	0.73	0.78	52.46K
Apr 21, 2026	0.72	0.75	0.71	0.72	13.91K
Apr 20, 2026	0.74	0.74	0.70	0.72	22.09K

Contact Details

Vancouver, BC V6C 1B4

Canada

https://www.inmedpharma.com 604 669 7207

About Company

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, the company works on IND-enabling pharmacology and preclinical toxicology studies; and IntegraSyn, an integrated biosynthesis-based manufacturing approach, for synthesizing pharmaceutical-grade cannabinoids. It has a research collaboration agreement with BayMedica Inc. for the manufacturing and testing of novel cannabinoid therapeutics. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is headquartered in Vancouver, Canada.

Stock Peers

ARGX

21.51+2.77%

argenx SE$797.77 REGN

0.62+0.10%

Regeneron Pharmaceuticals, Inc.$630.30 UTHR

-0.19-0.03%

United Therapeutics Corporation$566.80 MDGL

-10.41-1.99%

Madrigal Pharmaceuticals, Inc.$511.82 VRTX

-2.27-0.52%

Vertex Pharmaceuticals Incorporated$434.31 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

0.08+0.02%

Praxis Precision Medicines, Inc.$320.61 ALNY

8.03001+2.81%

Alnylam Pharmaceuticals, Inc.$294.30 KRYS

1.55+0.53%

Krystal Biotech, Inc.$293.30 ASND

0.34+0.14%

Ascendis Pharma A/S$237.98

Frequently Asked Questions

What is the current InMed Pharmaceuticals Inc. (INM) stock price?

InMed Pharmaceuticals Inc. (NASDAQ: INM) stock price is $1.60 in the last trading session. During the trading session, INM stock reached the peak price of $1.79 while $1.31 was the lowest point it dropped to. The percentage change in INM stock occurred in the recent session was 135.05% while the dollar amount for the price change in INM stock was $0.92.

INM's industry and sector of operation?

The NASDAQ listed INM is part of Biotechnology industry that operates in the broader Healthcare sector. InMed Pharmaceuticals Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of INM?

Dr. Sazzad Hossain M.Sc., Ph.D.
Co-Founder
Mr. Michael Woudenberg P.Eng.
Chief Operating Officer
Dr. Shane A. Johnson Ph.D.
Senior Vice President & GM of BayMedica
Ms. Sarah Li C.P.A., CGA
Vice President of Accounting & Controller
Ms. Brenda Edwards C.M.A., C.P.A.
Chief Accounting Officer
Dr. Ado Muhammad
Senior Consultant of Medical Affairs
Mr. Jonathan R. Tegge
Interim Chief Financial Officer
Ms. Sarah Li
Vice President of Accounting, Controller & Principal Accounting Officer
Dr. Eric Chih-Hsien Hsu
Senior Vice President of Preclinical R&D
Ms. Sarah Li CPA, CGA
Vice President of Accounting & Controller
Colin Clancy
Senior Director of Investor Relations
Ms. Alexandra Diane-Janet Mancini M.Sc.
Senior Vice President of Clinical & Regulatory Affairs
Mr. Jerry P. Griffin
Vice President of Sales & Marketing
Mr. Eric A. Adams B.S. Chem., M.I.B.
Pres, Chief Executive Officer & Director

How INM did perform over past 52-week?

INM's closing price is 178.26% higher than its 52-week low of $0.58 where as its distance from 52-week high of $7.98 is -79.95%.

How many employees does INM have?

Number of INM employees currently stands at 13.

Link for INM official website?

Official Website of INM is: https://www.inmedpharma.com

How do I contact INM?

INM could be contacted at phone 604 669 7207 and can also be accessed through its website. INM operates from 815 West Hastings Street, Vancouver, BC V6C 1B4, Canada.

How many shares of INM are traded daily?

INM stock volume for the day was 91.54M shares. The average number of INM shares traded daily for last 3 months was 1.62M.

What is the market cap of INM currently?

The market value of INM currently stands at $2.90M with its latest stock price at $1.60 and 1.81M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	13
Beta	0.46
Sales or Revenue	$4.94M
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

Employees	13
Beta	0.46
Sales or Revenue	$4.94M
5Y Sales Change%	0%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

INM Company Profile and Key Details

InMed Pharmaceuticals

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Company Overview

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Valuation Metrics

Price Forecast & Outlook

Key Takeaways